Now Available in the UK!Overwhelmingly, research indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic, and neuroendocrine functions. Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness. The GI-MAP (Microbial Assay Plus) is unique in comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more by targeting the specific DNA of the organisms tested. The GI-MAP is the only stool test that clinically evaluates the three significant dysbiosis patterns using qPCR technology in one test. 1. Insufficiency Dysbiosis: This pattern indicates a deficiency of beneficial commensal bacteria, vital for producing anti-inflammatory effects in the gut. 2. Inflammatory Dysbiosis: Characterised by inflammatory organisms that can lead to elevated endotoxin levels, this dysbiosis pattern is associated with acute symptoms and chronic health issues requiring intervention. 3. Digestive Insufficiency: Often overlooked in traditional stool tests, this pattern may stem from low stomach acid and insufficient digestive enzymes. The introduction of the StoolOMX add-on enhances the GI-MAP's capability by providing detailed insights into the production and reabsorption of primary and secondary bile acids. This digestive insufficiency is associated with the over-fermentation of food, leading to bloating and discomfort. Key Markers: Advanced qPCR detection, Zonulin, Inflammation Panel, Key Digestive Markers including Bile Acids, SCFAs, and H. pylori Sample: Type: Stool Turnaround Time: 3 Weeks Test Resources:GIMAP Product Brief Sample Report GIMAP Interpretive Guide + StoolOmx Interpretive Guide Understanding Common Dysbiosis Patterns NEW GIMAP Add on StoolOmx Product Brief StoolOmx - Interpretive Guide Instructions
Related
Related
Related
Related